Functional disruption of the moloney murine leukemia virus preintegration complex by vaccinia-related kinases.
Retroviral integration is executed by the preintegration complex (PIC), which contains viral DNA together with a number of proteins. Barrier-to-autointegration factor (BAF), a cellular component of Moloney murine leukemia virus (MMLV) PICs, has been demonstrated to protect viral DNA from autointegration and stimulate the intermolecular integration activity of the PIC by its DNA binding activity. Recent studies reveal that the functions of BAF are regulated by phosphorylation via a family of cellular serine/threonine kinases called vaccinia-related kinases (VRK), and VRK-mediated phosphorylation causes a loss of the DNA binding activity of BAF. These results raise the possibility that BAF phosphorylation may influence the integration activities of the PIC through removal of BAF from viral DNA. In the present study, we report that VRK1 was able to abolish the intermolecular integration activity of MMLV PICs in vitro. This was accompanied by an enhancement of autointegration activity and dissociation of BAF from the PICs. In addition, in vitro phosphorylation of BAF by VRK1 abrogated the activity of BAF in PIC function. Among the VRK family members, VRK1 as well as VRK2, which catalyze hyperphosphorylation of BAF, could abolish PIC function. We also found that treatment of PICs with certain nucleotides such as ATP resulted in the inhibition of the intermolecular integration activity of PICs through the dissociation of BAF. More importantly, the ATP-induced disruption was not observed with the PICs from VRK1 knockdown cells. Our in vitro results therefore suggest the presence of cellular kinases including VRKs that can inactivate the retroviral integration complex via BAF phosphorylation.
Laboratory for Host Factors, Center for Emerging Virus Research, Kyoto University, Kyoto 606-8507, Japan. ysuzuki@virus.kyoto-u.ac.jp
Yasutsugu
Y
Suzuki
Kanako
K
Ogawa
Yoshio
Y
Koyanagi
Youichi
Y
Suzuki
D000818:Animals; D003001:Cloning, Molecular; D004268:DNA-Binding Proteins / Q000378:metabolism; D051379:Mice; D008954:Models, Biological; D008979:Moloney murine leukemia virus / Q000201:enzymology* / Q000235:genetics*; D041681:NIH 3T3 Cells; D010766:Phosphorylation; D011485:Protein Binding; D011499:Protein Processing, Post-Translational; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D012190:Retroviridae / Q000235:genetics; D014616:Vaccinia virus / Q000201:enzymology*; D016662:Virus Integration
D004268:DNA-Binding Proteins; D011994:Recombinant Proteins; D017346:Protein Serine-Threonine Kinases; C484518:Vrk1 protein, mouse